TY  - JOUR
AU  - Stahl, Maximilian
AU  - DeVeaux, Michelle
AU  - Montesinos, Pau
AU  - Itzykson, Raphaël
AU  - Ritchie, Ellen K
AU  - Sekeres, Mikkael A
AU  - Majhail, Navneet
AU  - Barnard, John
AU  - Podoltsev, Nikolai A
AU  - Brunner, Andrew M
AU  - Komrokji, Rami S
AU  - Bhatt, Vijaya R
AU  - Al-Kali, Aref
AU  - Cluzeau, Thomas
AU  - Santini, Valeria
AU  - Roboz, Gail J
AU  - Fenaux, Pierre
AU  - Litzow, Mark
AU  - Fathi, Amir T
AU  - Perreault, Sarah
AU  - Kim, Tae Kon
AU  - Prebet, Thomas
AU  - Vey, Norbert
AU  - Verma, Vivek
AU  - Kobbe, Guido
AU  - Bergua, Juan
AU  - Serrano, Josefina
AU  - Gore, Steven D
AU  - Zeidan, Amer M
PY  - 2018
DO  - 10.1016/j.bbmt.2018.03.025
UR  - http://hdl.handle.net/10668/12340
T2  - Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
AB  - Patients with primary refractory or relapsed acute myeloid leukemia (RR-AML) have very poor prognosis. Due to limited treatment options, some patients are treated with hypomethylating agents (HMAs) due to their tolerability. Little is known about the...
LA  - en
KW  - AML
KW  - Hypomethylating agents
KW  - Survival
KW  - Transplant
KW  - Adult
KW  - Aged
KW  - Antimetabolites, Antineoplastic
KW  - Female
KW  - Graft vs Host Disease
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - Male
KW  - Middle Aged
KW  - Retrospective Studies
KW  - Salvage Therapy
KW  - Survival Analysis
KW  - Transplantation Conditioning
KW  - Transplantation, Homologous
TI  - Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study.
TY  - research article
VL  - 24
ER  -